₹173.22
▼ -2.8 -1.59%
As of 09 Sept 2026 · delayed
NSE Listed · Healthcare
Gujarat Kidney & Super Speciality Ltd. (GKSL)
Volume: 5,20,724Avg Vol 1W: 4,85,506Avg Vol 1M: 8,95,26952W Range:₹98.36₹180.9
Key Ratios
Checked 9h agoMarket Cap₹1,388 Cr
Current Price₹173.22
Previous Close₹176.02
High / Low (52w)₹180.9 / ₹98.36
Volume5,20,724
Avg Vol (1W)4,85,506
Avg Vol (1M)8,95,269
Stock P/E87.57
Book Value₹32.03
Dividend Yield0%
ROE6.14%
ROA5.62%
Revenue (TTM)—
Revenue Growth7.43%
Profit Margin15.67%
Total Debt₹2 Cr
Shares Outstanding8 Cr
Face Value₹2
EPS (TTM)₹2.01
P/B5.5
Debt / Equity0.39
50 DMA₹141.6
200 DMA—
Day change-1.59%
Price Chart
₹173.22▲ 65.70% · 1Y
2025-12-302026-09-09
20-day avg volume: 9.7L shares
Pros
- Company is almost debt-free.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 88.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹9 Cr | ₹12 Cr | ₹10 Cr | ₹15 Cr | ₹13 Cr | ₹23 Cr | ₹31 Cr | ₹34 Cr |
| EBITDA | ₹4 Cr | ₹4 Cr | ₹2 Cr | ₹8 Cr | ₹4 Cr | ₹6 Cr | ₹6 Cr | ₹8 Cr |
| Net Profit | ₹3 Cr | ₹3 Cr | ₹1 Cr | ₹5 Cr | ₹3 Cr | ₹3 Cr | ₹5 Cr | ₹5 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹9 Cr | ₹40 Cr | ₹8 Cr | ₹11 Cr | ₹10 Cr | ₹10 Cr | ₹9 Cr | ₹9 Cr |
| EBITDA | ₹3 Cr | ₹13 Cr | ₹2 Cr | ₹6 Cr | ₹3 Cr | ₹3 Cr | ₹1 Cr | ₹3 Cr |
| Net Profit | ₹2 Cr | ₹9 Cr | ₹1 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
| EPS | — | 1.85 | — | — | — | — | — | — |
Balance Sheet
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Total Assets | ₹4 Cr | ₹4 Cr | ₹21 Cr | ₹55 Cr |
| Total Liabilities | ₹4 Cr | ₹4 Cr | ₹10 Cr | ₹28 Cr |
| Equity | ₹0 Cr | ₹0 Cr | ₹11 Cr | ₹27 Cr |
| Total Debt | — | — | — | — |
Cash Flow
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Operating | ₹0 Cr | ₹1 Cr | ₹16 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹-18 Cr |
| Financing | ₹0 Cr | ₹0 Cr | ₹6 Cr |
| Free Cash Flow | ₹0 Cr | ₹1 Cr | ₹16 Cr |
Shareholding
Promoter 71.45% Institutions 5.44% Public 23.1%
Efficiency & Working Capital
ROCE8.2%
Interest Coverage20.7
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details
As of 2026-06-30
Promoter71.5%
FII4.9%
DII0.6%
Institutions5.4%
Public23.1%
Promoter Pledge0%
No. of Shareholders18,301
Shareholding Pattern
Quarterly — figures in %. Latest 4 quarters.
| Period | Mar 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Promoters | 99.1% | 71.5% | 71.5% | 71.5% |
| FIIs | 0% | 10.5% | 4.9% | 4.9% |
| DIIs | 0% | 1.7% | 0.6% | 0.6% |
| Public | 0.9% | 16.4% | 23.1% | 23.1% |
| Promoter Pledge | 0% | 0% | 0% | 0% |
| No. of Shareholders | 7 | 27,783 | 18,301 | 18,301 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202403 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Pragnesh Yashwantsinh Bharpoda | Shareholding of Promoter and Promoter Group | 38.2% | 3.01 Cr |
| Anitaben Nayak | Shareholding of Promoter and Promoter Group | 11.1% | 87,50,000 |
| Yashwantsingh Motisingh Bharpoda | Shareholding of Promoter and Promoter Group | 11.1% | 87,50,000 |
| Bhartiben Pragnesh Bharpoda | Shareholding of Promoter and Promoter Group | 11.1% | 87,49,475 |
| Craft Emerging Market Fund Pcc-citadel Capital Fund | Public Shareholding | 1.7% | 13,15,926 |
| Khandelwal Finance Private Limited | Public Shareholding | 1.7% | 13,16,096 |
| Nikita Yashvantsinh Bharpoda | Shareholding of Promoter and Promoter Group | 0% | 175 |
| Vihan Bharpoda | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Aarya Bharpoda | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Karansinh Surendrasinh Padwal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sumanben K Padwal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Hitendrasinh K Padwal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Tikamsinh Bharpoda | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Chatrasinh Bharpoda | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sampatben S Khasariya | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| BHARPODA PRAGNESH YASHWANTSINH | Chairman / Executive Director / M D / Promoter | 2025 |
| Anitaben Yashvantsinh Bharpoda | Non Executive Director | 2025 |
| Bhartiben Pragnesh Bharpoda | WTD & Executive Director | 2025 |
| Jagdish Vinodchandra Thakkar | Independent Director | 2025 |
| UDAYAN MAHESHKANT KACHCHHI | Independent Director | 2025 |
| Kairavi Naimesh Shah | Independent Director | 2025 |
| Niki Paresh Tiwari | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2024 | ₹10 | 4 | 0 | 0 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-14 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2024 | 0 | 0 | 0 | 14 | 0 | 15 |
| 2024 | 0 | 0 | 0 | 13 | 0 | 14 |
| 2024 | 0 | 0 | 0 | 2 | 0 | 2 |
Company Information
Incorporated2019
ChairmanBHARPODA PRAGNESH YASHWANTSINH
AuditorY M Shah & Co
Investor Email[email protected]
📍 Plot No.1 City Sarve No.1537/A, Jetalpur Rd Gokak Mill Compoun, Vadodara, Gujarat, 390020
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Ginnifilaments Ltd.Gujarat Industries Power Co Ltd.Giriraj Civil Developers Ltd.Grover Jewells LimitedGKB Ophthalmics Ltd.GK Energy LimitedGKW LimitedGland Pharma LimitedGlaxosmithkline Pharmaceuticals Ltd.Glenmark Pharmaceuticals Ltd.Gujarat Lease Financing LimitedGlobal Education LimitedAll “G” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search